WHO says Remdesivir has little or no effect on COVID-19 patients

WHO study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patients hospitalized with COVID-19.

Oct 16, 2020, 14:47 PM IST

Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in COVID-19 patients: WHO

Gilead Sciences Inc`s remdesivir had little or no effect on COVID-19 patients` length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.

Oct 16, 2020, 11:08 AM IST

One in three South Korean COVID-19 patients improve with remdesivir

One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condition after being given Gilead Sciences Inc`s antiviral remdesivir, health authorities said.

Jul 13, 2020, 10:20 AM IST

Remdesivir, Tocilizumab, Favipiravir cannot be sold without medical prescription, says Drug Control department

The Delhi government's Drug Control Department on Friday (July 11, 2020) said that COVID-19 drug namely Remdesivir, Tocilizumab, Favipiravir should only be used for emergency purpose and directed the state drugs controller to keep a check on the selling of these medicines.

Jul 11, 2020, 08:42 AM IST

COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir

The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.

Jun 21, 2020, 14:38 PM IST

Maharashtra to procure 10,000 vials of Remdesivir as COVID-19 cases reach 82,968

The Uddhav Thackeray-led Maha Vikas Aghadi government in Maharashtra will purchase 10,000 vials of the drug Remdesivir for treating coronavirus patients. The announcement was made by state’s Public Health Minister Rajesh Tope said on Saturday.

Jun 06, 2020, 20:37 PM IST

Gilead ties up with generic drugmakers in India, Pakistan for coronavirus COVID-19 drug supply

Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment remdesivir.

May 13, 2020, 07:17 AM IST

Data on Gilead drug remdesivir raises hopes in COVID-19 fight, Fauci calls it 'highly significant'

The top US infectious disease official said Gilead Sciences Inc`s experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early clinical trial results on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.

Apr 30, 2020, 11:01 AM IST